TipRanks
Go Ultimate55% OFF

Christopher David Taves Insider Profile

4 Followers

Christopher David Taves, Director at MediPharm Labs, holds 2.85M shares in MediPharm Labs (Ticker: MEDIF).

Christopher David Taves's Trading History

MEDIF
MediPharm Labs
Jun 13, 2026DirectorUninformative Sell―$136.70K
MEDIF
Insider Shares: 2.85M (67.03%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 13, 2026Informative SellC$13.26K176,786C$0.08+9.40%―
Jun 13, 2026Uninformative SellC$0.00392,857C$0.00――
Dec 15, 2025Uninformative SellC$0.00392,858C$0.00――
Jun 26, 2025Uninformative SellC$0.00392,856C$0.00――
Dec 12, 2024Uninformative SellC$0.00423,077C$0.00――

You May Also Like

Christopher David Taves insider profile FAQ

What is the percentage of profitable transactions made by Christopher David Taves?
The percentage of profitable transactions made by Christopher David Taves is 25%.
What is the average return per transaction made by Christopher David Taves?
The average return per transaction made by Christopher David Taves is -59.10%.
What stocks does Christopher David Taves hold?
Christopher David Taves holds: MEDIF stocks.
What was Christopher David Taves's most profitable transaction?
Christopher David Taves’s most profitable transaction was an Informative Sell of MEDIF stock on June 13, 2026. The return on the trade was 9.40%.
What is Christopher David Taves's role in MediPharm Labs?
Christopher David Taves's role in MediPharm Labs is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.